Jan 27, 2020 - The company recently received some great news about its cholesterol drug.
Jan 24, 2020 - J&J (JNJ) announces mixed Q4 results. Roche's (RHHBY) lymphoma drug, Polivy and Novartis' (NVS) Mayzent for secondary progressive multiple sclerosis (SPMS) get approval in Europe.
Jan 23, 2020 - Jazz (JAZZ) files regulatory application seeking approval for JZP-258, a low sodium formulation of Xyrem, in the United States.
Jan 23, 2020 - STMicroelectronics NV (NYSE:STM) Q4 2019 Earnings Conference Call January 23, 2020, 03:30 ET Company Participants Celine Berthier - Group VP, IR Jean-Marc - President & CEO Lorenzo Grandi - Presid
Jan 22, 2020 - ASML earnings call for the period ending December 31, 2019.
Jan 21, 2020 - Berkshire Hathaway Energy's (BRK.A, BRK.B) NV Energy says it is calling for proposals to add renewable energy projects that are compliant with Nevada's renewable portfolio standards.The company says i
Jan 21, 2020 - Novartis' (NVS) MS drug, Mayzent, obtains approval in Europe for the treatment of adult patients with secondary progressive multiple sclerosis.
Jan 21, 2020 - Jazz (JAZZ) receives approval for Sunosi as a treatment for excessive daytime sleepiness in narcolepsy or obstructive sleep apnea patients in Europe.
Jan 20, 2020 - Is Novartis AG (NVS) a great pick from the value investor's perspective right now? Read on to know more.
Jan 17, 2020 - SLB earnings call for the period ending December 31, 2019.